Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study.

Federico BertoliniGiovanni OstuzziMichela PievaniAndrea AgugliaFrancesco BartoliPaola BortolasoCamilla CallegariMariarita CaroleoGiuseppe CarràMariangela CorboArmando D'AgostinoPasquale De FazioFabio MaglioccoGiovanni MartinottiEdoardo Giuseppe OstinelliMarco Piero PiccinelliFederico TedeschiCorrado Barbuinull null

Published in: CNS drugs (2021)

Clinicians should be aware that LAI discontinuation is a frequent occurrence. LAI choice should be carefully discussed with the patient, taking into account individual characteristics and possible obstacles related to the practicalities of each formulation.

Keyphrases

risk assessment
case report
drug delivery
palliative care
randomized controlled trial
cross sectional
clinical trial